Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique antitumor specificity isolated from renal cell carcinoma ascitic fluid Arie BelldegrunAtan KasidSteven A. Rosenberg Original articles Pages: 1 - 10
Interleukin-2-dependent long-term cultures of low-density lymphocytes allow the proliferation of lymphokine-activated killer cells with natural killer, Tiγ/δ or TNK phenotype U. TestaA. CareC. Peschle Original articles Pages: 11 - 18
Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro F. VánkyP. WangE. Klein Original articles Pages: 19 - 27
Adoptive immunotherapy of a mouse colon carcinoma with recombinant interleukin-2 alone or combined with lymphokine-activated killer cells or tumor-immune lymphocytes Monica RodolfoCarolina SalviGiorgio Parmiani Original articles Pages: 28 - 36
Mouse tumors are heterogeneous in their susceptibility to syngeneic lymphokine-activated killer cells and delineate functional subsets in such effectors Marialuisa SensiLaura GrazioliGiorgio Parmiani Original articles Pages: 37 - 43
Natural killer and lymphokine-activated killer cell functions in chronic myeloid leukemia Nirmala RajaramRevati J. TatakeSudha G. Gangal Original articles Pages: 44 - 48
Interleukin-6 enhances the induction of human lymphokine-activated killer cells G. GallagherW. H. StimsonF. Al-Azzawi Original articles Pages: 49 - 52
Addition of interleukin-2in vitro augments detection of lymphokine-activated killer activity generatedin vivo Jacquelyn A. HankGilda Weil-HillmanPaul M. Sondel Original articles Pages: 53 - 59
Lysing of fresh human tumor by a cytotoxic factor derived from autologous large granular lymphocytes independently of other known cytokines Atsushi UchidaTakuya FujimotoYouich Mizutani Original articles Pages: 60 - 64